1921
Volume 98, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Current guidelines for the diagnosis of neurocysticercosis (NCC) recommend the use of the lentil lectin-bound glycoprotein enzyme-linked immunoelectrotransfer blot assay (LLGP-EITB) as the reference standard for serological testing. In response to the drawbacks involved with the use of the LLGP-EITB, a recombinant T24H antigen (rT24H) EITB assay was developed, with promising results. However, the test has yet to be evaluated among individuals from sub-Saharan Africa (SSA). The aim of the present study was to investigate the performance of the rT24H EITB assay for the detection of NCC cases in a panel of serum samples ( = 366, of which 173 patients presented with epileptic seizures and/or severe chronic headaches, and 193 matched manifestation-free participants) collected as part of a large community-based trial in Burkina Faso. A perfect agreement between the rT24H EITB and the native gp24 (and its homodimer, gp42) LLGP-EITB was found (kappa value of 1.0). Furthermore, among patients with the neurological manifestations of interest who underwent a computed tomography scan, the rT24H EITB and native antigen LLGP-EITB had a comparable ability to correctly identify NCC cases with multiple viable (rT24H: sensitivity: 80.0%), single viable (66.7%), and calcified/degenerating cysts only (25.0%), albeit for multiple viable and calcified cysts, the rT24H estimated sensitivity seemed lower, but more uncertain, than previously reported. The rT24H EITB specificity was high (98.2%) and in line with previous studies. This study confirms the value of the recombinant rT24H EITB as an alternative to the native antigen LLGP-EITB for the diagnosis of NCC in a SSA community setting.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.17-0541
2018-02-07
2019-03-25
Loading full text...

Full text loading...

/deliver/fulltext/14761645/98/2/tpmd170541.html?itemId=/content/journals/10.4269/ajtmh.17-0541&mimeType=html&fmt=ahah

References

  1. World Health Organization, 2012. Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases–A Roadmap for Implementation. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf?ua=1. Accessed July 7, 2017.
  2. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, Dickey M, Reynolds S, Stoner JA, , 2010. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870. [Google Scholar]
  3. Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, Stoner JA, Rainwater E, Dickey M, , 2011. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152. [Google Scholar]
  4. Del Brutto OH, Nash TE, White AC, Jr Rajshekhar V, Wilkins PP, Singh G, Vasquez CM, Salgado P, Gilman RH, Garcia HH, , 2017. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci 372: 202210. [Google Scholar]
  5. Winkler AS, Richter H, World Health Organization; , 2015. Landscape Analysis : Management of Neurocysticercosis with an Emphasis on Low- and Middle-Income Countries. Available at: http://www.who.int/taeniasis/resources/who_htm_ntd_nzd_2015.05/en/. Accessed July 7, 2017.
  6. Tsang VCW, Brand JA, Boyer AE, , 1989. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159: 5059. [Google Scholar]
  7. Noh J, Rodriguez S, Lee YMY-M, Handali S, Gonzalez AE, Gilman RH, Tsang VCW, Garcia HH, Wilkins PP, , 2014. Recombinant protein- and synthetic peptide-based immunoblot test for diagnosis of neurocysticercosis. J Clin Microbiol 52: 14291434. [Google Scholar]
  8. Wilson M, Bryan R, Fried J, Ware D, Schantz P, Pilcher J, Tsang V, , 1991. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164: 10071009. [Google Scholar]
  9. Deckers N, Dorny P, , 2010. Immunodiagnosis of Taenia solium taeniosis/cysticercosis. Trends Parasitol 26: 137144. [Google Scholar]
  10. Handali S, 2010. Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis. Clin Vaccine Immunol 17: 6872. [Google Scholar]
  11. Lee YM, 2011. Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA. Am J Trop Med Hyg 84: 587593. [Google Scholar]
  12. Hancock K, Pattabhi S, Whitfield FW, Yushak ML, Lane WS, Garcia HH, Gonzalez AE, Gilman RH, Tsang VCW, , 2006. Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol 147: 109117. [Google Scholar]
  13. Carabin H, Millogo A, Cissé A, Gabriël S, Sahlu I, Dorny P, Bauer C, Tarnagda Z, Cowan LD, Ganaba R, , 2015. Prevalence of and factors associated with human cysticercosis in 60 villages in three provinces of Burkina Faso. PLoS Negl Trop Dis 9: 120. [Google Scholar]
  14. Jensen R, Stovner LJ, , 2008. Epidemiology and comorbidity of headache. Lancet Neurol 7: 354361. [Google Scholar]
  15. Landis J, Koch G, , 1977. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33: 363374. [Google Scholar]
  16. Landis J, Koch G, , 1977. The measurement of observer agreement for categorical data. Biometrics 33: 159174. [Google Scholar]
  17. R Core Team, 2016. R: A Language and Environment for Statistical Computing. Available at: http://www.r-project.org/. Accessed July 7, 2017.
  18. Furrows SJ, McCroddan J, Bligh WJ, Chiodini P, , 2006. Lack of specificity of a single positive 50-kDa band in the electroimmunotransfer blot (EITB) assay for cysticercosis. Clin Microbiol Infect 12: 459462. [Google Scholar]
  19. Singhi P, , 2011. Neurocysticercosis. Ther Adv Neurol Disorder 4: 6781. [Google Scholar]
  20. Zea-Vera A, 2013. Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only. Clin Infect Dis 57: 154159. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.17-0541
Loading
/content/journals/10.4269/ajtmh.17-0541
Loading

Data & Media loading...

Supplemental Material

  • Received : 07 Jul 2017
  • Accepted : 30 Oct 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error